Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa

East African Medical Journal

Volumn 75, Issue 6, 1998, Pages 358-363

  Nuwaha, F ^a  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE;

DISEASE CONTROL; HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS; TUBERCULOSIS;

AFRICA; ARTICLE; CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DRUG COMBINATION; DRUG INTERMITTENT THERAPY; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; OUTPATIENT CARE; SEROLOGY; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADULT; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMBULATORY CARE; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; ENDEMIC DISEASES; HEALTH SERVICES NEEDS AND DEMAND; HIV SEROPREVALENCE; HUMANS; PATIENT SELECTION; RISK FACTORS; TUBERCULOSIS; UGANDA;

AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031738829     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kochi A. The global tuberculosis situation and the new control strategies of the World Health Organization. Tubercle. 1991; 72:1-6.
2. World Health Organization; Tuberculosis control and research strategies for the 1990s: Memorandum from a WHO meeting. Bull. Wld Hlth Organ. 1992; 70:17-21
3. Reider H.L., Cauthen M.G., Comstock W.G. and Snider D.E. Epidemiology of tuberculosis in the United States, Epidem. rev. 1989; 11:79-98.
4. Allen S., Batungwanayo J. and Kerliwowke et al; Two year incidence of tuberculosis in cohorts of HIV infected and uninfected urban women. Amer. Rev. Respir. Dis. 1992; 146:1439-44
5. Raviglione M.C., Narain J.P. and Kochi A. HIV associated tuberculosis in developing countries: clinical features, diagnosis and treatment. Bull. Wld. Hlth. Organ. 1992; 70:515-526
6. Styblo K. The relationship between the risk of developing tuberculosis infection and the risk of developing infectious tuberculosis. Bull. Int. Un. Tuberc. 1985; 60:117-119
7. Schulzer M., Fitzgerald J.M., Enarson D.A. and Grzybowski S. An estimate of the future size of the tuberculosis problem in Sub-Saharan Africa resulting from HIV infection. Tuberc. Lung Dis. 1992; 73:52-58.
8. Murray, J.L., Styblo K. and Rouillon A. Tuberculosis in developing countries burden intervention and cost. Bull. Intern. Un. tuber. Lung Dis. 1990; 65: 1-24
9. Maikin J.E., Prazouk T. and Simmonet F. et al. Tuberculosis and HIV infection: a longitudinal study in West Africa: Burkina Faso. In: Programme and Abstracts of the Sixth International Conference on AIDS: .Tune 20-24. 1990 San Francisco California, Abstract ThC 733.
10. Standaert B., Niragira F., Kadende P. and Piot P. The association of tuberculosis and Human immune deficiency virus infection in Burundi. Aids Res. Hum. Retrovir. 1989; 5: 247-251.
11. Cathebras P., Vomto J.A. and Yeta M.L. et al: HIV infection among patients with tuberculosis in Bangui, Central African Republic: a prospective study. In Program and abstracts of the XII th International Congress on tropical Medicine and Malaria 1988. Int Congress series 1988; 810: 66r.
12. Decock K.M., Gnaore E. and Adjorlolo et al. Risk of tuberculosis in patients with HIV 1 and HIV 2 infections in Abidjan, Ivory Coast. Brit. Med. J. 1991; 302:496-499.
13. Nunn P.P., Kibuga D. and Gathua S. et al: Cutaneous hypersensitivity reactions due to thioacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet. 1991; 377:627-630.
14. Kelly, P., Bumham G. and Radford C. HIV seropositivity and tuberculosis in a rural Malawi hospital. Trans. roy. Soc. Trop. Med. Hyg. 1990; 84:725-727.
15. Wright J. and Ford H. Tuberculosis and HIV infection. Brit. Med. J. 1991: 302:160-3.
16. Wilkinson, D. High Compliance tuberculosis treatment programme in a rural community. Lancet. 1995; 313: 647-48.
17. Eriki, P.P., Okwera, A., Asu, I., Morrisay, B.A., Ellner, J.J. and Daniel, M.T. the influence of Human immune deficiency virus infection on tuberculosis in Kampala, Uganda. Amer. Rev. Respir. Dis. 1991; 143:185-187.
18. Nuwaha, F.N. The control of tuberculosis in Uganda today: are the problems surmountable given the Human immunodeficiency virus epidemic, in Abstracts of Tuberculosis-towards 2000 13-17 March, 1994, MRC National Research Programme, Pretoria, South Africa.
19. Migliori, G.B., borghesi, A. and Adriko, C. et al. tuberculosis and HIV infection association in a rural district of Northern Uganda: epidemiological and clinical considerations. Tubercle and Lung dis. 1992; 73:285-290.
20. Colebunders, R.L., Ryder, W. R., Nzilambi, N.M., et al. HIv infection in patients with tuberculosis in Kinshasa, Zaire. Amer. Rev. Respir. Dis. 1989; 139:1082-85.
21. Elliot, A.M., Luo, N., Tembo, G., Haliwindi, B. and Mcadaa, K.P.W.J. Impact of HIv on tuberculosis in Zambia: a cross sectional study. Brit. Med. J. 1990; 301:412-415.
22. Mahari, M., Legg., W. and Houston, S. et al. Association of tuberculosis and HIV infection in Zimbabwe. In program and abstracts of the sixth international conference on AIDs: June 20-24. 1990 San Francisco California, Abstract FC 608.
23. Stott, H., Patel, A. and Sutherland, I. et al. The risk of tuberculous infection in Uganda, derived from the findings of naitonal tuberculin surveys in 1958 and 1970. Tubercle. 1973; 54:1-24.
24. AIDS Control Programme. AIDS Surveillance report, fourth quarter 1996. Ministry of Health, Entebbe, Uganda.
25. Decock M.K., Grant A. and Porter J.D.H. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research and practise? Lancet. 1995; 345:833-836.
26. Aisu T., Raviglione M.C. and Van Praag F. et al. Preventive chemotherapy for HIV associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 1995; 9:267-73.
27. Jonghe D.E., Murray C.J.L., Chum H.J., Nyangulu, D.S., Salomao A. and Styblo K. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. Intern. J. Hlth Plan. Manage. 1994; 9:151-181.
28. Eriki P.P. Whither tuberculosis: Uganda's experience. Presented at the third symposium on AIDSand related cancers in Africa 1988, Arusha, Tanzania.
29. Styblo K. Epidemiology of tuberculosis. The Hague: Royal Netherlands Tuberculosis Association Selected papers 1991, volume 24.
30. Okot-Nwang, M., Wabwire-Maugen F. and Kagezi V.B.A. Increasing prevalence of tuberculosis among Mulago hospital admissions Kampala, Uganda. Tuberc. Lung Dis. 1993; 73:52-8
31. Nuwaha, F.N. The Integration of tuberculosis control into PHC in Uganda during the era of epidemic. J. Comprehen. Hlth. 1995; 6:46-48.
32. Mukadi Y., Perriens J. and Willame J.C. et al; Prolonged chemotherapy for tuberculosis following standard SCC among HIV infected persons in Zaire. Proceedings of the VII International conference on AIDS Florence, Italy, 16-20 June 1991. Abstract M.B. 2176:226.
33. Perriens J., Colebunders R.L. and Karuhanga C. et al; Increased mortality and tuberculosis treatment failure rate among human immunodefeciency virus (HIV) sero-positive compared with HIV sero-negative patients with pulmonary tuberculosis, treated with "standard chemotherapy in Kinshasa, Zaire. Amer. rev. respir. dis. 1991; 144:750-755
34. Nunn P.P., Brindle R. and Carpenter L.M. et al; Cohort study of HIV infection in tuberculosis patients, Nairobi Kenya: analysis of early six months mortality. Amer. Rev. Respir. Dis 1992; 146: 849-854
35. World Health Organization Severe hypersensitivity reactions among HIV seropositive patients with tuberculosis treated with thioacetazone. Wkly Epidem. Rec. 1992; 67:1-3
36. World Health Organization The integration of tuberculosis contiol in Primary Health Care, World Health Organization 1988, Geneva, Switzerland.
37. Tuberculosis Chemotherapy Centre Madras. A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Bull. Wld. Hlth. Org. 1959; 21:51-144.
38. Nuwaha F.N. Factors influencing completion of treatment among tuberculosis patients in Mbarara district, Uganda. East Afr. Med. J. 1997; 74:90-93.
39. World Health Organization. 1997 World TB Day.Activities, Global Tuberculosis Programme, World Health Organization 1997, Geneva Switzerland.
40. National Tuberculosis and Leprosy Programme, Ministry of Health Uganda, Guidelines for National Demonstration and training Districts Implementing Directly Observed Treatment, Short course, Ministry of Health Working Draft may, 1997, Kampala Uganda.
41. Toman K. Tuberculosis case finding and chemotherapy. Questions and Answers. World Health Organization 1979, Geneva Switzerland.